# South Carolina Poll Shows Bipartisan Support for Legal Hemp > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/bipartisan-support-legal-hemp-sc-poll/ > **Published:** 2026-04-24T10:57:18-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:12:48-04:00 > **Clinical Summary:** A South Carolina poll reveals bipartisan support legal hemp despite looming restrictions, highlighting public opinion favoring hemp product access. --- ✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyHempIndustry Clinical Summary A South Carolina poll reveals substantial bipartisan support among voters for maintaining legal access to hemp products, even as federal and state regulatory restrictions potentially tighten. The survey demonstrates that both Republican and Democratic constituents favor hemp legalization, suggesting public opinion may diverge from anticipated policy changes that could limit availability of hemp-derived cannabinoids like CBD and delta-8 THC. This disconnect between voter preference and regulatory direction has significant implications for clinicians whose patients currently use hemp products for pain management, anxiety, sleep, and other conditions. If restrictions are implemented despite public support, patients may lose access to over-the-counter hemp products they have come to rely on, potentially increasing demand for [pharmaceutical alternatives](https://cedclinic.com/substitution-medical-cannabis-pharmaceutical-agents/) or illicit sources. Clinicians should be aware of evolving hemp regulations in their states and consider counseling patients on potential access changes while documenting current use patterns for continuity of care. Clinicians treating South Carolina patients should monitor upcoming legislative changes and discuss alternative management strategies with patients currently using legal hemp products, given the uncertain regulatory landscape. Dr. Caplan’s Take “What we’re seeing in South Carolina mirrors the national trend: patients and voters understand that hemp-derived cannabinoids have legitimate therapeutic applications, and they’re ahead of policymakers on this issue. If we restrict access based on plant morphology rather than actual pharmacology or harm profile, we’re making clinical decisions by legislative convenience rather than evidence, and that ultimately costs patients who could benefit from these treatments.” Clinical Perspective ⚕️ As South Carolina considers tightening hemp regulations, recent polling indicating bipartisan public support for legal hemp reflects a broader tension between evolving consumer demand and regulatory caution that clinicians should monitor. The gap between popular opinion and restrictive policy creates an environment where patients may increasingly seek hemp-derived products outside formal medical channels, potentially including unregulated or misrepresented cannabinoid products that lack quality assurance and transparent labeling. Healthcare providers should be prepared to discuss the distinction between regulated [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/), hemp-derived [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/), and the varying legal and safety profiles of these substances, while acknowledging that current evidence remains limited for many clinical applications. Clinicians should document patient use of hemp and cannabinoid products in medical histories, particularly given potential interactions with medications and the risk of using such products as substitutes for evidence-based treatments. Understanding the local regulatory landscape and maintaining non-judgmental conversations about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) will help providers better serve 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+As+hemp+restrictions+loom%2C+SC+poll+shows+bipartisan+support+for+legal+hemp+-+WCBD+%40drcaplan&url=https%3A%2F%2Fwww.counton2.com%2Fnews%2Fsouth-carolina-news%2Fas-hemp-restrictions-loom-sc-poll-shows-bipartisan-support-for-legal-hemp%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.counton2.com%2Fnews%2Fsouth-carolina-news%2Fas-hemp-restrictions-loom-sc-poll-shows-bipartisan-support-for-legal-hemp%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+As+hemp+restrictions+loom%2C+SC+poll+shows+bipartisan+support+for+legal+hemp+-+WCBD+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.counton2.com%2Fnews%2Fsouth-carolina-news%2Fas-hemp-restrictions-loom-sc-poll-shows-bipartisan-support-for-legal-hemp%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Bipartisan Bill Would Let States Sidestep Hemp THC Ban – Forbes](https://cedclinic.com/hemp-derived-cannabinoid-products-access-expands/) - [What Pending Medical Cannabis and Hemp Legislation Means for Georgia | JD Supra](https://cedclinic.com/georgia-medical-cannabis-legislation-update/) - [CED Digest: 230 Items — March 18, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) 📰 Source: [https://www.counton2.com/news/south-carolina-news/as-hemp-restrictions-loom-sc-poll-shows-bipartisan-support-for-legal-hemp/](https://www.counton2.com/news/south-carolina-news/as-hemp-restrictions-loom-sc-poll-shows-bipartisan-support-for-legal-hemp/) Further Reading Research Digest[Research Digest: 10 Recent Studies – April 22, 2026](https://cedclinic.com/recent-cannabinoid-clinical-research-april-2026/) CED Clinic Blog[Cannabinoids and Chronic Pain: 2025 Evidence Review](https://cedclinic.com/cannabinoids-chronic-pain-clinical-outcomes-2025/) Evidence Watch[Neuropathic Pain Severity Is Associated With Opioid Use in Adults With Traumatic Spinal Cord Injury: A Spinal Cord Injury Model System Study.](https://cedclinic.com/opioid-use-neuropathic-pain-spinal-cord-injury/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Bipartisan Bill Would Let States Sidestep Hemp THC Ban – Forbes](https://cedclinic.com/hemp-derived-cannabinoid-products-access-expands/) Explore how bipartisan legislation aims to allow states to bypass federal hemp THC restrictions, impacting hemp industry regulations. [Read More](https://cedclinic.com/hemp-derived-cannabinoid-products-access-expands/) [New state law could hamstring Ohio’s struggling hemp industry – Farm and Dairy](https://cedclinic.com/new-state-law-could-hamstring-ohios-struggling-hemp-industry-farm-and-dairy/) Learn about new state laws affecting Ohio’s hemp industry and the challenges faced by hemp farmers and businesses. [Learn More](https://cedclinic.com/new-state-law-could-hamstring-ohios-struggling-hemp-industry-farm-and-dairy/) [With hemp rules tightening, users worry about access to THC-infused products](https://cedclinic.com/delta-8-thc-regulatory-changes-patient-access/) Understand user concerns regarding tightening hemp regulations and the impact on access to THC-infused hemp products. [Discover More](https://cedclinic.com/delta-8-thc-regulatory-changes-patient-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).